
The best Bull and Bear pitches based on recency and number of recommendations.
I don't know why this biotech is so grossly undervalued. I think it is because it is not an American company. But the p/e is well below industry average and the good news about pipeline and approvals just keep pouring in.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about RHHBY.
Recs
I bought this stock 2 weeks ago @$45.60 mainly for the reasons below and I believe it will will out perform the S & P in the coming months,
The U.S. Food and Drug Administration has granted breakthrough therapy designation to Roche Holding AG's gantenerumab for the treatment of people living with Alzheimer's disease.
Roche: Phase 2/3 Trial of Covid-19 Treatment Ronapreve met its primary endpoint.
Results from the trial show that Ronapreve, which is a combination of two antibodies, casirivimab and imdevimab, "significantly" reduces the viral load within seven days in patients who have been hospitalized with Covid-19, the pharmaceutical company said.
Recs
Leader in DNA diagnostic testing.
Recs
Diagnostics demand for health care
Find the members with the highest scoring picks in RHHBY.
climate (73.32) Score: +359.42
The Score Leader is the player with the highest score across all their picks in RHHBY.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
climate | 73.32 | 3/9/2009 |
![]() |
1Y | $11.30 | +217.36% | +576.77% | +359.42 | 1 Comment | |
mikep757 | < 20 | 12/22/2008 |
![]() |
3Y | $14.75 | +142.97% | +422.45% | +279.48 | 0 Comment | |
CvsIndnsFan2830 | 69.09 | 3/18/2008 |
![]() |
1Y | $18.33 | +95.54% | +265.67% | +170.13 | 0 Comment | |
Master1958jade | < 20 | 7/4/2008 |
![]() |
NS | $17.78 | +101.66% | +262.50% | +160.84 | 0 Comment | |
Lonewolf7107 | < 20 | 11/12/2012 |
![]() |
5Y | $20.21 | +77.36% | +228.51% | +151.15 | 0 Comment | |
MrOneHundred | 29.96 | 11/19/2012 |
![]() |
NS | $19.91 | +80.06% | +229.78% | +149.71 | 0 Comment | |
RafaelCanadaRed | 82.07 | 5/7/2013 |
![]() |
5Y | $27.39 | +30.87% | +180.49% | +149.62 | 0 Comment | |
wsb1999 | 63.42 | 4/10/2008 |
![]() |
NS | $18.34 | +95.45% | +244.69% | +149.24 | 0 Comment | |
zkoerber | 97.03 | 10/7/2010 |
![]() |
1Y | $14.20 | +152.43% | +293.22% | +140.79 | 0 Comment | |
GrandeTeam | 25.59 | 11/16/2011 |
![]() |
5Y | $16.13 | +122.22% | +260.72% | +138.50 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.